journal article·2016-01-02Open access

Orally delivered microencapsulated probiotic formulation favorably impacts polyp formation in APC (Min/+) model of intestinal carcinogenesis

Aleksandra Malgorzata Urbanska, Jasmine Bhathena, Sofiane Cherif, Satya Prakash

Abstract

The development of intestinal polyps in an orthotopic colorectal mouse model, receiving a probiotic yogurt formulation containing microencapsulated live Lactobacillus acidophilus cells was investigated. The expression of various immunohistochemical markers namely CD8, Mac-1, Ki-67, and cleaved caspase-3, was evaluated. Results suggest that the probiotic formulation decreases overall intestinal inflammation. Mice receiving the probiotic formulation were found to develop almost two-fold fewer tumors in the small intestines. In the large intestine, however, there was no significant difference observed among polyp numbers. The formulation appears to have potential application in the prevention of various GI pathological conditions.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Gut microbiota and health · Probiotics and Fermented Foods · Digestive system and related health

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Biomedical Technology and Cell Therapy Research Laboratory, Departments of Biomedical Engineering and Physiology Artificial cells and Organs Research Center, Faculty of Medicine, McGill University, University Street, Montreal, QC, Canada

References (42)

Show source-provided references
1. Ahn B · Cancer Res · 2001 · 61 · 8357
2. 10.1111/j.1440-1827.2005.01808.x10.1111/j.1440-1827.2005.01808.x ↗
3. Austin EB · Immunology · 1998 · 67 · 525
4. 10.1093/carcin/16.2.24510.1093/carcin/16.2.245 ↗
5. 10.1007/s00253-007-0908-x10.1007/s00253-007-0908-x ↗
6. 10.1042/BA2007000710.1042/BA20070007 ↗
7. 10.1073/pnas.95.2.68110.1073/pnas.95.2.681 ↗
8. 10.1038/nature0132210.1038/nature01322 ↗
9. 10.1007/s00401005087610.1007/s004010050876 ↗
10. Donoghue S · Cancer Res · 1999 · 59 · 5386
11. 10.1111/j.0105-2896.2005.00291.x10.1111/j.0105-2896.2005.00291.x ↗
12. 10.1079/BJN200262810.1079/BJN2002628 ↗
13. 10.1073/pnas.070662510410.1073/pnas.0706625104 ↗
14. 10.1097/MOG.0b013e3282f2b0e810.1097/MOG.0b013e3282f2b0e8 ↗
15. 10.1128/CVI.13.2.219-226.200610.1128/CVI.13.2.219-226.2006 ↗
16. 10.1016/S0016-5085(03)00171-910.1016/S0016-5085(03)00171-9 ↗
17. 10.1016/j.ccr.2009.01.00110.1016/j.ccr.2009.01.001 ↗
18. 10.1038/nature1146510.1038/nature11465 ↗
19. 10.1055/s-0029-124245810.1055/s-0029-1242458 ↗
20. 10.1136/gut.33.11.152810.1136/gut.33.11.1528 ↗
21. 10.1159/00008534210.1159/000085342 ↗
22. 10.1203/00006450-198707000-0001710.1203/00006450-198707000-00017 ↗
23. 10.1016/j.clnu.2010.05.00410.1016/j.clnu.2010.05.004 ↗
24. 10.1111/j.1462-5822.2008.01137.x10.1111/j.1462-5822.2008.01137.x ↗
25. 10.1016/j.ccr.2013.10.00910.1016/j.ccr.2013.10.009 ↗
26. 10.1023/A:101294120251010.1023/A:1012941202510 ↗
27. Lauritsen K · Gastroenterology · 1986 · 91 · 83710.1016/0016-5085(86)90684-0 ↗
28. 10.1093/jn/135.5.99610.1093/jn/135.5.996 ↗
29. 10.1093/carcin/bgp19710.1093/carcin/bgp197 ↗
30. Naito Y · Cancer Res · 1998 · 58 · 3491
31. 10.1002/ijc.144010.1002/ijc.1440 ↗
32. 10.1136/gut.33.4.52410.1136/gut.33.4.524 ↗
33. 10.1038/nature0882110.1038/nature08821 ↗
34. 10.1016/S0016-5085(98)70196-910.1016/S0016-5085(98)70196-9 ↗
35. 10.1172/JCI3058710.1172/JCI30587 ↗
36. 10.1126/science.135010810.1126/science.1350108 ↗
37. 10.1136/gut.32.9.107110.1136/gut.32.9.1071 ↗
38. 10.1016/0092-8674(95)90127-210.1016/0092-8674(95)90127-2 ↗
39. 10.1016/j.ccr.2008.10.01110.1016/j.ccr.2008.10.011 ↗
40. Ucello M · BMC Surgery · 2012 · 12 · S3510.1186/1471-2482-12-S1-S35 ↗
41. 10.1139/Y07-05710.1139/Y07-057 ↗
42. 10.1073/pnas.94.4.140210.1073/pnas.94.4.1402 ↗